Patient stories

Reimagining Patient Care

Pioneering Transformative Therapies to Empower Patients' Lives - The Essence of Our Mission from the Start.

Today, BioVersys is advancing transformative therapies with a patient-centric approach. BV100 is at the forefront, targeting carbapenem-resistant Acinetobacter baumannii infections in the lungs and bloodstream, with the potential to set a new standard in care. In collaboration with GSK, we are also developing Alpibectir, a pioneering drug aimed at combating tuberculosis and its meningitis form, promising a novel treatment avenue when combined with ethionamide. These efforts reflect our dedication to addressing urgent patient needs.

BioVersys understands the importance of listening to those we serve. We are passionate about developing new life-saving therapies to address life-threatening medical conditions that increasingly devastate our society and to make a significant and positive impact on public health.

The Story of Akshay:

Akshay, a tuberculosis survivor, shares his TB journey and emphasizes the challenges he faced during diagnosis, treatment and stigma. His experience inspired him to share his story and pursue a career dedicated to recruit others in the fight against AMR and tuberculosis. By raising public awareness and encouraging proactive measures, Akshay aims to minimize the impact of the disease and provide hope and support to individuals on their path to recovery. You can learn more about his experience by watching the video.

UNIVERSITY HOSPITAL BASEL: A PATIENT’S STORY:

In this insightful interview, we follow the extraordinary story of a patient overcoming the aftermath of a severe motorcycle accident in Medellín, Colombia. It chronicles the initial emergency response, including urgent treatments and surgeries in Colombia, and the journey back to Basel for advanced medical care. This patient’s experience sheds light on the challenges of a serious lower leg fracture, the complications of infection and antimicrobial resistance, and the comprehensive care strategies employed by healthcare professionals. Watch the video to explore his medical journey and the inspiring resilience demonstrated in overcoming such a critical health challenge.

DISCLAIMER:
The stories featured on this page are developed in collaboration with the individuals or patients involved and are published with their explicit consent. Alternatively, some stories may be sourced from a third party, also with the individual's consent, for BioVersys to showcase. The stories displayed on this page have been prepared with the sole objective of raising awareness of the troubling health issues of tuberculosis and antimicrobial resistance (AMR) and are shared for educational purposes only. Any collaboration between individuals or patients and BioVersys is of a non-commercial nature with no financial or other incentives provided by either party to the other party. No individuals or patients have participated in any of BioVersys’ clinical trials, nor do they endorse any of BioVersys’ projects or products in any way. BioVersys does not assume any responsibility for the correctness, completeness, and suitability of the content presented here by the individual or patient. Any questions regarding a medical condition, treatment, or decisions about participating in a clinical trial should always be directed to a healthcare professional. Individual results and situations may vary. Please respect the current local and international data protection and privacy regulations, and do not download, copy or reproduce in any way the content presented here.

Scroll to Top